Cite

HARVARD Citation

    De Vincentis, A. et al. (2022). Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid. Liver international. pp. 2453-2465. [Online]. 
  
Back to record